Abstract:Saikosaponin D (SSD), derived from Bupleurum falcatum L., has various pharmacological properties, including immunoregulatory, anti-inflammatory, and anti-allergic effects. Several studies have investigated the anti-tumor effects of SSD on cancer in multiple organs. However, its role in colorectal cancer (CRC) remains unclear. Therefore, this study aimed to elucidate the suppressive effects of SSD on CRC cell survival and metastasis. SSD reduced the survival and colony formation ability of CRC cells. SSD-induced autophagy and apoptosis in CRC cells were measured using flow cytometry. SSD treatment increased LC3B and p62 autophagic factor levels in CRC cells. Moreover, SSD-induced apoptosis occurred through the cleavage of caspase-9, caspase-3, and PARP, along with the downregulation of the Bcl-2 family. In the in vivo experiment, a reduction in the number of metastatic tumor nodules in the lungs was observed after the oral administration of SSD. Based on these results, SSD inhibits the metastasis of CRC cells to the lungs by inducing autophagy and apoptosis. In conclusion, SSD suppressed the proliferation and metastasis of CRC cells, suggesting its potential as a novel substance for the metastatic CRC treatment.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to explore the inhibitory effect of Saikosaponin D (SSD) on the survival and lung metastasis of colorectal cancer (CRC) cells. Specifically, the study aims to clarify the ability of SSD to inhibit CRC cell survival and metastasis by inducing autophagy and apoptosis. ### Research Background and Problems - **Colorectal Cancer (CRC)**: Colorectal cancer is a common malignant tumor mainly affecting the colon and rectum. Globally, it is the third most common cancer and the second leading cause of cancer - related deaths. In South Korea, the incidence of CRC ranks second, and the mortality rate ranks third. - **Metastatic CRC**: Approximately 25% of CRC patients have distant metastases at the initial diagnosis, and 50% of these patients will eventually develop metastatic diseases. The most common metastatic sites of CRC are the liver and lungs. - **Current Treatment Situation**: Currently, the treatment of metastatic CRC mainly includes chemotherapy, surgery, and radiotherapy, but these methods are often accompanied by severe side effects, such as hair loss, nausea, vomiting, and diarrhea. Therefore, it is particularly important to find new treatment methods. ### Research Objectives - **Explore the Mechanism of Action of SSD**: SSD is a compound extracted from the roots of Bupleurum, which has multiple pharmacological activities, including immunomodulatory, anti - inflammatory, and anti - allergic effects. Previous studies have shown that SSD has anti - tumor effects on cancers in multiple organs, but its impact on CRC has not been clear. - **Experimental Design**: Through in vitro and in vivo experiments, study the inhibitory effect of SSD on CRC cell survival and lung metastasis, and explore its mechanism of action, especially achieving this effect by inducing autophagy and apoptosis. ### Main Research Contents - **Cell Experiments**: - **Cell Survival Rate Detection**: Use the WST method to detect the survival rate of CRC cells after SSD treatment. - **Clonogenic Ability Detection**: Evaluate the impact of SSD on the clonogenic ability of CRC cells. - **Autophagy Detection**: Detect SSD - induced autophagy by analyzing the protein levels of LC3B and p62 through flow cytometry and Western blot. - **Apoptosis Detection**: Detect SSD - induced apoptosis by analyzing the expression of apoptosis - related proteins (such as caspase - 3, caspase - 9, PARP, and Bcl - 2 family proteins) through the Annexin V method and Western blot. - **Animal Experiments**: - **Lung Metastasis Model**: Establish a mouse lung metastasis model injected with CT26 cells to evaluate the effect of oral administration of SSD on lung metastasis. - **Histological Analysis**: Further verify the mechanism of action of SSD by analyzing the expression of autophagy - and apoptosis - related proteins in lung tissues through Western blot. ### Research Results - **In Vitro Experiments**: - SSD significantly reduced the survival rate and clonogenic ability of CRC cells. - SSD induced autophagy in CRC cells, manifested as an increase in the protein levels of LC3B and p62. - SSD induced apoptosis in CRC cells by activating caspase - 3, caspase - 9, and PARP and down - regulating Bcl - 2 family proteins. - **In Vivo Experiments**: - Oral SSD significantly reduced the number of metastatic tumor nodules in the lungs of mice. - Western blot analysis showed that after SSD treatment, the protein levels of LC3B and p62 in lung tissues increased, the protein levels of Bcl - 2 and Bcl - xL decreased, and the cleavage of caspase - 3, caspase - 8, caspase - 9, and PARP increased. ### Conclusion This study confirmed that SSD effectively inhibits the survival and lung metastasis of CRC cells by inducing autophagy and apoptosis. These results suggest that SSD may become a new candidate drug for the treatment of metastatic CRC.

Saikosaponin D Inhibits Lung Metastasis of Colorectal Cancer Cells by Inducing Autophagy and Apoptosis

Saikosaponin‐D induces the pyroptosis of lung cancer by increasing ROS and activating the NF‐κB/NLRP3/caspase‐1/GSDMD pathway

Saikosaponin-d Suppresses COX2 Through p-STAT3/C/EBPβ Signaling Pathway in Liver Cancer: A Novel Mechanism of Action

Chemopreventive effect of saikosaponin-d on diethylinitrosamine-induced hepatocarcinogenesis: involvement of CCAAT/enhancer binding protein β and cyclooxygenase-2

Saikosaponin D potentiates the antineoplastic effects of doxorubicin in drug-resistant breast cancer through perturbing NQO1-mediated intracellular redox balance

Saikosaponin D exerts cytotoxicity on human endometrial cancer ishikawa cells by inducing apoptosis and inhibiting metastasis through MAPK pathways

Saikosaponin d modulates the polarization of tumor-associated macrophages by deactivating the PI3K/AKT/mTOR pathway in murine models of pancreatic cancer

Saikosaponin D Inducing Apoptosis and Autophagy through the Activation of Endoplasmic Reticulum Stress in Glioblastoma

Dioscin Facilitates ROS-induced Apoptosis Via the P38-Mapk/hsp27-mediated Pathways in Lung Squamous Cell Carcinoma

Advances in the anti-tumor mechanisms of saikosaponin D

Saikosaponin d contributed to cancer chemotherapy induced neutropenia therapy by promoting neutrophil differentiation via activation CBL-dependent ERK pathway

Salvianolic acid B suppresses EMT and apoptosis to lessen drug resistance through AKT/mTOR in gastric cancer cells

Saikosaponin D Alleviates DOX-induced Cardiac Injury In Vivo and In Vitro

Saikosaponin A Enhances Docetaxel Efficacy by Selectively Inducing Death of Dormant Prostate Cancer Cells Through Excessive Autophagy.

Saikosaponin D from Radix Bupleuri suppresses triple-negative breast cancer cell growth by targeting β-catenin signaling

Saikosaponin D alleviates cancer cachexia by directly inhibiting STAT3

Salvianolic Acid B, A Novel Autophagy Inducer, Exerts Antitumor Activity As A Single Agent in Colorectal Cancer Cells

4-Acetyl-Antroquinonol B Suppresses SOD2-Enhanced Cancer Stem Cell-Like Phenotypes and Chemoresistance of Colorectal Cancer Cells by inducing hsa-miR-324 re-Expression

Safflower Polysaccharide Inhibits AOM/DSS-Induced Mice Colorectal Cancer Through the Regulation of Macrophage Polarization

Cryptotanshinone Inhibits the Growth of HCT116 Colorectal Cancer Cells Through Endoplasmic Reticulum Stress-Mediated Autophagy

Saikosaponin A Inhibits Growth of Human Bladder Carcinoma T24 and 5637 Cells Both in Vitro and in Vivo